• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝癌微环境中的信号分子。

Signaling molecules in the microenvironment of hepatocellular carcinoma.

机构信息

Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China.

The Key Laboratory of Molecular Biology of Infectious Diseases Designated By the Chinese Ministry of Education, Chongqing Medical University, Chongqing, 400016, China.

出版信息

Funct Integr Genomics. 2024 Aug 29;24(5):146. doi: 10.1007/s10142-024-01427-7.

DOI:10.1007/s10142-024-01427-7
PMID:39207523
Abstract

Hepatocellular carcinoma (HCC) is a major fatal cancer that is known for its high recurrence and metastasis. An increasing number of studies have shown that the tumor microenvironment is closely related to the metastasis and invasion of HCC. The HCC microenvironment is a complex integrated system composed of cellular components, the extracellular matrix (ECM), and signaling molecules such as chemokines, growth factors, and cytokines, which are generally regarded as crucial molecules that regulate a series of important processes, such as the migration and invasion of HCC cells. Considering the crucial role of signaling molecules, this review aims to elucidate the regulatory effects of chemokines, growth factors, and cytokines on HCC cells in their microenvironment to provide important references for clarifying the development of HCC and exploring effective therapeutic targets.

摘要

肝细胞癌(HCC)是一种主要的致命癌症,其复发和转移率很高。越来越多的研究表明,肿瘤微环境与 HCC 的转移和侵袭密切相关。HCC 微环境是一个由细胞成分、细胞外基质(ECM)和趋化因子、生长因子和细胞因子等信号分子组成的复杂综合系统,通常被认为是调节 HCC 细胞迁移和侵袭等一系列重要过程的关键分子。鉴于信号分子的重要作用,本综述旨在阐明趋化因子、生长因子和细胞因子在 HCC 细胞微环境中的调节作用,为阐明 HCC 的发生发展和探索有效的治疗靶点提供重要参考。

相似文献

1
Signaling molecules in the microenvironment of hepatocellular carcinoma.肝癌微环境中的信号分子。
Funct Integr Genomics. 2024 Aug 29;24(5):146. doi: 10.1007/s10142-024-01427-7.
2
The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages.肝细胞癌中的炎症微环境:肿瘤相关巨噬细胞的关键作用。
Biomed Res Int. 2013;2013:187204. doi: 10.1155/2013/187204. Epub 2012 Dec 30.
3
Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways.癌症相关成纤维细胞通过趋化因子激活的刺猬信号通路和转化生长因子-β通路促进肝细胞癌转移。
Cancer Lett. 2016 Aug 28;379(1):49-59. doi: 10.1016/j.canlet.2016.05.022. Epub 2016 May 20.
4
Role of chemokines in hepatocellular carcinoma (Review).趋化因子在肝细胞癌中的作用(综述)。
Oncol Rep. 2021 Mar;45(3):809-823. doi: 10.3892/or.2020.7906. Epub 2020 Dec 22.
5
HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.在缺氧肿瘤微环境中,缺氧诱导因子-1α(HIF-1α)通过上调赖氨酰氧化酶样蛋白2(LOXL2)促进肝细胞癌中的血管生成拟态形成。
J Exp Clin Cancer Res. 2017 Apr 27;36(1):60. doi: 10.1186/s13046-017-0533-1.
6
ADAR1 p110 Enhances Adhesion of Tumor Cells to Extracellular Matrix in Hepatocellular Carcinoma via Up-Regulating ITGA2 Expression.ADAR1 p110 通过上调 ITGA2 表达增强肝癌细胞与细胞外基质的黏附。
Med Sci Monit. 2019 Feb 24;25:1469-1479. doi: 10.12659/MSM.911944.
7
The tumor microenvironment in hepatocellular carcinoma (review).肝细胞癌的肿瘤微环境(综述)。
Int J Oncol. 2012 Jun;40(6):1733-47. doi: 10.3892/ijo.2012.1408. Epub 2012 Mar 22.
8
Components of the Hepatocellular Carcinoma Microenvironment and Their Role in Tumor Progression.肝细胞癌微环境的组成部分及其在肿瘤进展中的作用。
Biochemistry (Mosc). 2017 Aug;82(8):861-873. doi: 10.1134/S0006297917080016.
9
The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets.肝细胞癌的肿瘤微环境:现状和治疗靶点。
Semin Cancer Biol. 2011 Feb;21(1):35-43. doi: 10.1016/j.semcancer.2010.10.007. Epub 2010 Oct 12.
10
Long Non-Coding RNAs as Mediators of Tumor Microenvironment and Liver Cancer Cell Communication.长链非编码 RNA 作为肿瘤微环境与肝癌细胞通讯的介体。
Int J Mol Sci. 2018 Nov 24;19(12):3742. doi: 10.3390/ijms19123742.

引用本文的文献

1
The tumor microenvironment in hepatocellular carcinoma: mechanistic insights and therapeutic potential of traditional Chinese medicine.肝细胞癌中的肿瘤微环境:中医的机制见解与治疗潜力
Mol Cancer. 2025 Jun 10;24(1):173. doi: 10.1186/s12943-025-02378-8.

本文引用的文献

1
TACE plus lenvatinib and tislelizumab for intermediate-stage hepatocellular carcinoma beyond up-to-11 criteria: a multicenter cohort study.TACE 联合仑伐替尼和替雷利珠单抗治疗超 11 项入组标准的中期肝细胞癌:一项多中心队列研究。
Front Immunol. 2024 Jul 26;15:1430571. doi: 10.3389/fimmu.2024.1430571. eCollection 2024.
2
Analysis of the DNA-binding properties of TGF-β-activated Smad complexes unveils a possible molecular basis for cellular context-dependent signaling.对转化生长因子-β激活的Smad复合物的DNA结合特性进行分析,揭示了细胞环境依赖性信号传导可能的分子基础。
FASEB J. 2024 Aug 15;38(15):e23877. doi: 10.1096/fj.202400978R.
3
Atezolizumab in Combination with Bevacizumab for the Management of Patients with Hepatocellular Carcinoma in the First-Line Setting: Systematic Literature Review and Meta-Analysis.
阿替利珠单抗联合贝伐单抗一线治疗肝细胞癌患者的系统文献综述和荟萃分析
Liver Cancer. 2023 Jul 29;12(6):510-520. doi: 10.1159/000533166. eCollection 2023 Dec.
4
Expression of CXCL12-CXCR4/CXCR7 chemokines in splenic fibrosis of cirrhotic spleen and its therapeutic significance.CXCL12-CXCR4/CXCR7趋化因子在肝硬化脾脏脾纤维化中的表达及其治疗意义
Arch Med Sci. 2023 Aug 25;19(5):1569-1575. doi: 10.5114/aoms/170910. eCollection 2023.
5
FGF9 Recruits β-Catenin to Increase Hepatic ECM Synthesis and Promote NASH-Driven HCC.FGF9 通过招募β-catenin 增加肝脏细胞外基质合成并促进 NASH 驱动的 HCC。
Adv Sci (Weinh). 2023 Oct;10(28):e2301166. doi: 10.1002/advs.202301166. Epub 2023 Aug 11.
6
Pulmonary interleukin 1 beta/serum amyloid A3 axis promotes lung metastasis of hepatocellular carcinoma by facilitating the pre-metastatic niche formation.肺内白细胞介素 1β/血清淀粉样蛋白 A3 轴通过促进转移前生态位形成促进肝细胞癌的肺转移。
J Exp Clin Cancer Res. 2023 Jul 13;42(1):166. doi: 10.1186/s13046-023-02748-4.
7
The role of CXCL family members in different diseases.CXCL家族成员在不同疾病中的作用。
Cell Death Discov. 2023 Jul 1;9(1):212. doi: 10.1038/s41420-023-01524-9.
8
CXCL10 mediates CD8 T cells to facilitate vessel normalization and improve the efficacy of cetuximab combined with PD-1 checkpoint inhibitors in colorectal cancer.CXCL10 介导 CD8 T 细胞促进血管正常化,并提高西妥昔单抗联合 PD-1 检查点抑制剂治疗结直肠癌的疗效。
Cancer Lett. 2023 Jul 28;567:216263. doi: 10.1016/j.canlet.2023.216263. Epub 2023 Jun 22.
9
Blocking the CXCL1-CXCR2 axis enhances the effects of doxorubicin in HCC by remodelling the tumour microenvironment via the NF-κB/IL-1β/CXCL1 signalling pathway.阻断CXCL1-CXCR2轴可通过NF-κB/IL-1β/CXCL1信号通路重塑肿瘤微环境,增强阿霉素对肝癌的治疗效果。
Cell Death Discov. 2023 Apr 10;9(1):120. doi: 10.1038/s41420-023-01424-y.
10
Secreted protease PRSS35 suppresses hepatocellular carcinoma by disabling CXCL2-mediated neutrophil extracellular traps.分泌蛋白酶 PRSS35 通过使 CXCL2 介导的中性粒细胞胞外陷阱失活来抑制肝细胞癌。
Nat Commun. 2023 Mar 18;14(1):1513. doi: 10.1038/s41467-023-37227-z.